Patents by Inventor Jun Sub PARK

Jun Sub PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID FORMULATION COMPRISING A FUSION PROTEIN INCLUDING a-GALACTOSIDASE A
    Publication number: 20250161211
    Abstract: The present invention relates to a liquid formulation including a fusion protein of ?-galactosidase A and a preparation method thereof, wherein the liquid formulation not only has storage stability by including a composition providing structural stability to a fusion protein of ?-galactosidase A, but also has excellent stability although the fusion protein is contained at a high concentration.
    Type: Application
    Filed: March 10, 2023
    Publication date: May 22, 2025
    Inventors: Miroo KIM, Miri YOO, Jae Woon SON, Da-eui PARK, Shin-Ae YI, Jin Young KIM, Jun Sub PARK, Doo Seo JANG, Sung Hee HONG, Sang Yun KIM
  • LYOPHILIZED FORMULATION COMPRISING A FUSION PROTEIN INCLUDING a-GALACTOSIDASE A
    Publication number: 20250099558
    Abstract: The present invention relates to a lyophilized formulation including a fusion protein of ?-galactosidase A and a preparation method thereof, wherein the lyophilized formulation not only has storage stability by including a composition providing structural stability to a fusion protein of ?-galactosidase A, but also has excellent stability although the fusion protein is contained at a high concentration.
    Type: Application
    Filed: March 10, 2023
    Publication date: March 27, 2025
    Inventors: Miroo KIM, Miri YOO, Jae Woon SON, Da-eui PARK, Shin-Ae YI, Jin Young KIM, Jun Sub PARK, Doo Seo JANG, Sung Hee HONG, Sang Yun KIM
  • NOVEL CONJUGATE OF IMMUNE-STIMULATING IL-2 ANALOG AND PREPARATION METHOD THEREOF
    Publication number: 20240009317
    Abstract: The present invention relates to a long-acting conjugate of an interleukin-2 analog with altered binding affinity for interleukin-2 receptors.
    Type: Application
    Filed: March 31, 2022
    Publication date: January 11, 2024
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Yong Ho HEO, Euh Lim OH, Da Hyeon PARK, Jin Young KIM, Jun Sub PARK, Yu Yon KIM, A Ram LEE, Sang Yun KIM
  • IMMUNOSTIMULATING IL-2 ANALOGS
    Publication number: 20230348550
    Abstract: Modifications to interleukin-2 alpha receptors are disclosed. Interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors are disclosed.
    Type: Application
    Filed: July 10, 2023
    Publication date: November 2, 2023
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Euh Lim OH, Sang Yun KIM, Yong Ho HEO, Jin Young KIM, Cho Rong PARK, Jun Sub PARK, Hyun Soo RYU
  • Immunostimulating IL-2 analogs
    Patent number: 11746137
    Abstract: The present invention relates to changes in interleukin-2 alpha receptors and interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: September 5, 2023
    Assignee: HANMI PHARM. CO., LTD.
    Inventors: Euh Lim Oh, Sang Yun Kim, Yong Ho Heo, Jin Young Kim, Cho Rong Park, Jun Sub Park, Hyun Soo Ryu
  • NOVEL IMMUNOSTIMULATING IL-2 ANALOGS
    Publication number: 20230124171
    Abstract: The present invention relates to changes in interleukin-2 alpha receptors and interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors.
    Type: Application
    Filed: March 31, 2021
    Publication date: April 20, 2023
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Euh Lim OH, Sang Yun KIM, Yong Ho HEO, Jin Young KIM, Cho Rong PARK, Jun Sub PARK, Hyun Soo RYU